Experts use multi-disciplinary approach to provide innovative care for children

September 11, 2017

More than one-third of children with malignant liver tumors eventually require a liver transplant.  This center will bring together all of the doctors that a patient will need during their treatment, from oncologists to transplant surgeons. The likelihood of a good outcome for a patient with an extensive liver tumor, both in terms of a cure and quality of life after treatment, is high when the care is provided in a multidisciplinary setting like the Liver Tumor Center, where there is direct access to the pediatric liver transplant program at Texas Children's Hospital, the largest program in the southern United States.  

"The goal is to rapidly integrate advances in molecular biology into clinical practice," said Milton Finegold, M.D., one of the world's pre-eminent pathology experts on liver tumors. Dr. Finegold is Chief Emeritus of the pathology service at Texas Children's, professor of pathology and pediatrics at Baylor College of Medicine and the lead pathologist for liver tumors in the National Cancer Institute-funded Children's Oncology Group.  Finegold adds, "Combining our efforts is a huge step in improving our ability to diagnose and treat liver tumors."

Within the multidisciplinary center, clinicians and scientists meet regularly to discuss each patient's treatment plan and coordinate care in a way that takes advantage of the unique expertise of all the doctors and researchers involved.  Efforts to identify different types of tumors based on their genetic background will eventually lead to personalized medicine, in which therapy is individualized for each patient and their particular cancer. This personalized approach will result in increased cures with fewer side effects.

SOURCE Texas Children's Hospital